The mortality rate from respiratory system diseases in Australia has shown fluctuations between 2013 and 2023, with a noticeable dip in 2020, likely influenced by pandemic-related factors. From 2013 to 2023, rates varied, with key decreases in 2018 and 2020, and a notable incrementary recovery in subsequent years, leading to 65.5 deaths per hundred thousand persons in 2023. Particularly significant were the year-on-year changes, showing marked decreases in 2018 (-12.88%) and 2020 (-24.43%), but also substantial rebounds in 2019 (8.87%) and 2022 (18.74%). The CAGR over the last 5 years (2023) stood at 1.47%.
Future Trends to Watch For:
- Stabilization: The forecast indicates a relatively stable trend from 2024 onwards, with slight annual increases, culminating in 66.2 deaths per hundred thousand persons by 2028.
- Impact of healthcare advancements: Potential breakthroughs in treating respiratory diseases may reduce mortality rates.
- Environmental factors: Changes in pollution levels and respiratory disease prevalence could influence future trends significantly.
- Demographic shifts: Aging population trends may affect the mortality rate due to heightened vulnerability to respiratory conditions.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...